Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1364670

registered interest
date	29/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when data collection for the Cancelled Elective Operations dataset will be resumed for inclusion in planned publication of the quarter 3 2021-22 data set in 2022.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	66203
answer	answer is ministerial correction date of answer 04/11/2021 answer text <p>The collection will resume for Quarter 3 2021/22, to be published in February 2022.</p><p>The decision on data on cancelled or postponed operations is determined based on a balanced assessment, to collect timely and clinically valuable data. There are currently no official plans to introduce new data. When considering future changes to data published, NHS England and NHS Improvement will take account of the views of the clinicians, patients and stakeholder organisations.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 66204 question first answered 04/11/2021 17:47:27 answering member 4362 label Biography information for Edward Argar previous answer version 29990 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4397 label Biography information for Peter Dowd

1364671

registered interest
date	29/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to include data on operations cancelled or postponed for non-clinical reasons by NHS Trusts according to specialty when the publication of the Cancelled Elective Operations dataset is resumed.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	66204
answer	answer is ministerial correction date of answer 04/11/2021 answer text <p>The collection will resume for Quarter 3 2021/22, to be published in February 2022.</p><p>The decision on data on cancelled or postponed operations is determined based on a balanced assessment, to collect timely and clinically valuable data. There are currently no official plans to introduce new data. When considering future changes to data published, NHS England and NHS Improvement will take account of the views of the clinicians, patients and stakeholder organisations.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 66203 question first answered 04/11/2021 17:47:27 answering member 4362 label Biography information for Edward Argar previous answer version 29994 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4397 label Biography information for Peter Dowd

1364381

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to tackle supply issues surrounding HRT products.
tabling member constituency	Belfast South
tabling member printed	Claire Hanna
uin	65535
answer	answer is ministerial correction date of answer 04/11/2021 answer text <p>The Department is aware of supply issues that are affecting a very limited number of hormone replacement therapy (HRT) products. We have been working closely with all suppliers to help to maintain overall supply to patients in the United Kingdom. We have shared regular updates about these issues and management advice with the National Health Service and the Royal College of Obstetricians and Gynaecologists.</p><p>A range of HRT preparations remain available to patients through the NHS. This includes a variety of both oestrogen-only HRT preparations in oral tablets, transdermal patches and gels and Estradiol/progesterone combination products marketed as tablets and transdermal patches.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 65536 question first answered 04/11/2021 15:57:12 answering member 4362 label Biography information for Edward Argar previous answer version 29987 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4827 label Biography information for Claire Hanna

1364402

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the (a) range and (b) variety of HRT products available to patients through the NHS.
tabling member constituency	Belfast South
tabling member printed	Claire Hanna
uin	65536
answer	answer is ministerial correction date of answer 04/11/2021 answer text <p>The Department is aware of supply issues that are affecting a very limited number of hormone replacement therapy (HRT) products. We have been working closely with all suppliers to help to maintain overall supply to patients in the United Kingdom. We have shared regular updates about these issues and management advice with the National Health Service and the Royal College of Obstetricians and Gynaecologists.</p><p>A range of HRT preparations remain available to patients through the NHS. This includes a variety of both oestrogen-only HRT preparations in oral tablets, transdermal patches and gels and Estradiol/progesterone combination products marketed as tablets and transdermal patches.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 65535 question first answered 04/11/2021 15:57:12 answering member 4362 label Biography information for Edward Argar previous answer version 29988 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4827 label Biography information for Claire Hanna

1363513

registered interest
date	26/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Healthcare products Regulatory Agency: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of maintaining funding for the Medicines and Healthcare products Regulatory Agency at its current level.
tabling member constituency	Ealing Central and Acton
tabling member printed	Dr Rupa Huq
uin	63807
answer	answer is ministerial correction date of answer 01/11/2021 answer text <p>The Department has made no such assessment. As an executive agency of the Department, the Medicines and Healthcare products Regulatory Agency (MHRA) makes a robust assessment of its funding. We will continue to invest in the MHRA and the detail of its funding allocation will be confirmed in due course following the Spending Review.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 01/11/2021 10:59:40 answering member 4362 label Biography information for Edward Argar previous answer version 28966 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4511 label Biography information for Dr Rupa Huq

1362975

registered interest
date	25/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fampridine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on access to Fampridine by people with multiple scleroris.
tabling member constituency	Chipping Barnet
tabling member printed	Theresa Villiers
uin	62639
answer	answer is ministerial correction date of answer 01/11/2021 answer text <p>We have had no such discussions. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on whether medicines represent a clinical and cost-effective use of resources.</p><p>NICE was unable to recommend fampridine in its clinical guideline on managing multiple sclerosis (MS) which was originally published in 2014. However, NICE is now updating this guideline, which will include reviewing the recommendation on fampridine. NICE expects to publish its draft guidance on the management of MS for consultation in December this year, with final guidance expected on 1 June 2022.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 01/11/2021 10:48:50 answering member 4362 label Biography information for Edward Argar previous answer version 28692 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	1500 label Biography information for Theresa Villiers

1362994

registered interest
date	25/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding he plans to make available to the eight pathfinder trusts in the New Hospital Programme to deliver new facilities; and what recent assessment he has made of adequacy of that planned funding.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	62856
answer	answer is ministerial correction date of answer 01/11/2021 answer text <p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts’ specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class="ministerial">West Hertfordshire Hospitals NHS Trust has</del> <ins class="ministerial">pathfinder trusts have</ins> £117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers’ money.</p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 01/11/2021 14:24:35 question first ministerially corrected 01/12/2021 16:38:32 answering member 4362 label Biography information for Edward Argar previous answer version 29120 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4769 label Biography information for Daisy Cooper

1362995

registered interest
date	25/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will to publish a timeline for releasing funds for the detailed design and enabling works required from West Hertfordshire Hospitals NHS Trust and the other seven pathfinder trusts to help those trusts meet the New Hospital Programme’s timescale.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	62857
answer	answer is ministerial correction date of answer 01/11/2021 answer text <p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts’ specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class="ministerial">West Hertfordshire Hospitals NHS Trust has</del> <ins class="ministerial">pathfinder trusts have</ins> £117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers’ money.</p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 01/11/2021 14:24:35 question first ministerially corrected 29/11/2021 13:12:56 answering member 4362 label Biography information for Edward Argar previous answer version 29121 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4769 label Biography information for Daisy Cooper

1362996

registered interest
date	25/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether it remains his policy for the pathfinder trusts to start construction in 2023 and be ready to open by 2027 at the latest as part of the New Hospital Programme.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	62858
answer	answer is ministerial correction date of answer 01/11/2021 answer text <p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts’ specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class="ministerial">West Hertfordshire Hospitals NHS Trust has</del> <ins class="ministerial">pathfinder trusts have </ins>£117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers’ money.</p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 01/11/2021 14:24:35 question first ministerially corrected 01/12/2021 16:38:23 answering member 4362 label Biography information for Edward Argar previous answer version 29122 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4769 label Biography information for Daisy Cooper

1362482

registered interest
date	22/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to reply to the letter on behalf of a constituent from the hon. Member for Garston and Halewood of August 10 2021 on student nurse debt and the abolition of nurses and allied trades bursaries.
tabling member constituency	Garston and Halewood
tabling member printed	Maria Eagle
uin	61117
answer	answer is ministerial correction date of answer 04/11/2021 answer text <p>We responded to the hon. Member’s letter on 1 November 2021.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 04/11/2021 17:57:02 answering member 4362 label Biography information for Edward Argar previous answer version 28158 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	483 label Biography information for Maria Eagle